Expert Opinion on Therapeutic Patents, Volume 26, Issue 12 (2016)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 26, Issue 12 (2016)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Volume 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Patent Evaluation

Article
Compounds and methods for inhibiting histone demethylases: a patent evaluation of US20160102096A1
Florian Thaler & Ciro Mercurio
Pages: 1367-1370
Published online: 21 Oct 2016
AbstractforCompounds and methods for inhibiting histone demethylases: a patent evaluation of US20160102096A1 | Full Text | References | PDF (385 KB)
  • 221 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927
Victor V. Dotsenko, Elena A. Chigorina & Sergey G. Krivokolysko
Pages: 1371-1376
Published online: 10 Nov 2016
Abstractfor2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927 | Full Text | References | PDF (878 KB)
  • 84 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Review
Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015)
Sandy Elbitar, Petra El Khoury, Youmna Ghaleb, Jean-Pierre Rabès, Mathilde Varret, Nabil G. Seidah, Catherine Boileau & Marianne Abifadel
Pages: 1377-1392
Published online: 12 Jul 2016
AbstractforProprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015) | Full Text | References | PDF (1.2 MB) | Supplemental
  • 579 Views
  • 22 CrossRef citations
  • 0Altmetric
Review
Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature
Graham S. Timmins
Pages: 1393-1398
Published online: 10 Aug 2016
AbstractforStable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature | Full Text | References | PDF (513.8 KB)
  • 143 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents
Vijay K. Singh, Patricia L.P. Romaine, Victoria L. Newman & Thomas M. Seed
Pages: 1399-1408
Published online: 09 Sep 2016
AbstractforMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents | Full Text | References | PDF (950 KB)
  • 2874 Views
  • 27 CrossRef citations
  • 0Altmetric
Open Access
Review
Sphingosine kinase inhibitors: a review of patent literature (2006-2015)
Kevin R. Lynch, S. Brandon Thorpe & Webster L. Santos
Pages: 1409-1416
Published online: 30 Aug 2016
AbstractforSphingosine kinase inhibitors: a review of patent literature (2006-2015) | Full Text | References | PDF (1.1 MB)
  • 645 Views
  • 22 CrossRef citations
  • 0Altmetric
Review
Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review
Emanuela Teveroni, Rossella Lucà, Marsha Pellegrino, Germana Ciolli, Alfredo Pontecorvi & Fabiola Moretti
Pages: 1417-1429
Published online: 20 Sep 2016
AbstractforPeptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review | Full Text | References | PDF (1.2 MB)
  • 458 Views
  • 14 CrossRef citations
  • 0Altmetric
Review
Medical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents
Vijay K. Singh, Melissa Garcia, Stephen Y. Wise & Thomas M. Seed
Pages: 1431-1447
Published online: 14 Sep 2016
AbstractforMedical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents | Full Text | References | PDF (1.4 MB)
  • 3815 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Review
Case study of patents related to captopril, Squibb’s first blockbuster
Adelaide Maria de Souza Antunes, Rafaela Di Sabato Guerrante, Jorge de Paula Costa Ávila, Flavia Maria Lins Mendes & Iolanda M. Fierro
Pages: 1449-1457
Published online: 01 Sep 2016
AbstractforCase study of patents related to captopril, Squibb’s first blockbuster | Full Text | References | PDF (1.1 MB)
  • 204 Views
  • 5 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez et al.
Review Article | Published online: 19 Jul 2024
A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020–present
Xiaoling Huang et al.
Review Article | Published online: 17 Jul 2024
Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present)
Shirong Bian et al.
Review Article | Published online: 15 Jul 2024
The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present)
Chen Zhang et al.
Review Article | Published online: 9 Jul 2024
View all latest articles